English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
10 results
Process for promoting weight loss in overweight dogs
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
The present invention relates to a process and product for promoting weight loss in overweight dogs, and more particularly to a process for supplementing a canine diet with L-carnitine to promote weight loss, improve body composition, and enhance satiety in the animal.
It
Composition for the prevention and/or treatment of disorders due to abnormal lipid metabolism, comprising propionyl L-carnitine and chitosan
Only registered users can translate articles
Log In/Sign up
The present invention relates to a composition suitable for the prevention and/or treatment of disorders due to abnormal lipid metabolism, such as hypercholesterolaemia, atherosclerosis, hyperlipidaemia and obesity, comprising as characterising active ingredients propionyl L-carnitine or a
Method for decreasing the appetite in bulimic, overweight individuals
Only registered users can translate articles
Log In/Sign up
SUMMARY OF THE INVENTION
The present invention relates to a method for controlling and decreasing the appetite in overweight individuals and to 5-hydroxytryptophan (5-HTP)-containing anorectic pharmaceutical compositions.
According to its broadest aspect the invention relates to the coordinated use
Carnitine carrier related protein-1
Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION
The present invention is directed to polynucleotides encoding the Carnitine Carrier Related Protein-1 (CCRP-1) protein, fragments thereof, and the regulatory regions located at the 5'- and 3'-end of the CCRP-1 gene. The invention also concerns polypeptides encoded by the
Compositions and methods for reducing or preventing obesity
Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION
The invention relates to nutrition of companion and other domestic animals. In particular, the invention provides compositions and methods in which isoflavones, conjugated linoleic acid, and L-carnitine are used alone or in combination in food, food supplements and the like,
Compositions and methods for reducing or preventing obesity
Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION
The invention relates to nutrition of companion and other domestic animals. In particular, the invention provides compositions and methods in which isoflavones, conjugated linoleic acid, and L-carnitine are used alone or in combination in food, food supplements and the like,
.beta.-hydroxy-.gamma.-aminophosphonates and methods for the preparation and use thereof
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention is in the field of medicinal chemistry. In particular, the invention relates to carnitine analogs such as .beta.-hydroxy-.gamma.-aminophosphonates and .beta.-amino-.gamma.-aminophosphonates that inhibit carnitine acyltransferases,
.beta.-hydroxy-.gamma.-aminophosphonates and methods for the preparation and use thereof
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention is in the field of medicinal chemistry. In particular, the invention relates to carnitine analogs such as .beta.-hydroxy-.gamma.-aminophosphonates and .beta.-amino-.gamma.-aminophosphonates that inhibit carnitine acyltransferases,
Use of L-acetylcarnitine, L-isovalerylcarnitine, L-propionylcarnitine for increasing the levels of IGF-1
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
Field of the Invention
The present invention relates to a novel therapeutic use of L-acetylcarnitine, L-isovalerylcarnitine, L-propionylcarnitine or pharmacologically acceptable salts thereof for increasing the levels of IGF-1 (insulin-like growth factor 1) for the
Composition of skin external application containing ginseng berry extracts
Only registered users can translate articles
Log In/Sign up
This application is the U.S. national phase of International Application No. PCT/KR2008/003069, filed 30 May 2008, which designated the U.S. and claims priority to Korean Patent Application No. 10-2007-0053097, filed 31 May 2007, the entire contents of each of which are hereby incorporated by
The most complete medicinal herbs database backed by science
- Works in 55 languages
- Herbal cures backed by science
- Herbs recognition by image
- Interactive GPS map - tag herbs on location (coming soon)
- Read scientific publications related to your search
- Search medicinal herbs by their effects
- Organize your interests and stay up do date with the news research, clinical trials and patents
Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research
